BioAustinCTX’s Post

WHO: Biotech and Pharma companies in the San Francisco Bay Area WHEN: 19 September, 12-2pm WHERE: The Lighthouse Cafe in Oyster Point WHAT: A Lunch & Learn event And most importantly... WHY: Meet with experts from across the Australian Clinical Trial Ecosystem and learn about the benefits of running early phase studies down there. REGISTER: https://lnkd.in/gYHT8g2P When runway is precious and efficiency is paramount, look to Australia to get your phase 1 study started sooner, completed promptly, and done less expensively. Return to the US IND process with your phase 1 complete and human data in hand and get a jumpstart on the coming biotech boom.

Kicking off #DCATWeek, six key industry leaders gathered for a round table to discuss their respective companies’ participation and share industry views. Hayley Crowe, Ecolab EVP & GM, Global Life Sciences, was among the participants involved in the discussion. Read their perspectives in the article from the Life Sciences Knowledge Hub. #DCAT | #DCATWeek2024

Our new #BrainHealthTimeMatters is now available: https://lnkd.in/eDavWAg So many have made this work possible. Our thanks go to Alexion Pharma Germany GmbH and Merck Healthcare for sponsoring the launch of this report and helping bring this work to all; to Roche, MS Society and Horizon, now part of Amgen for their critical support towards the development of the report; to the panel of authors Helmut Butzkueven, Gavin Giovannoni, Sofia Arkelsten, Giancarlo Comi, Kathy Costello, Michael Devlin, Jelena Drulovic, Emma Gray, Jodi Haartsen, Anne Helme, Jana Hlaváčová, Elisabeth Kasilingam, Yaou Liu, Thomas Mathew, Saul Reyes, Jérôme de Sèze and Mitzi Joi Williams M.D., FAAN and to the many members of the Working Groups named in the report who brought expertise and evidence to shape and support the recommendations. We thank you and look forward the next steps - collaborating with you and further stakeholders to support the implementation of the recommendations. #BrainHealthTM #BrainHealth #MSTimeMatters, #NMOSDTimeMatters, #MOGADTimeMatters, #MSBH #OHPF, The Sumaira Foundation, Sumaira Ahmed, EMSP - European Multiple Sclerosis Platform, MS International Federation (MSIF), Can Do MS

It’s published 👏 a collaboration with over 60 experts across geography and disciplines. Delve in and see what it can mean for you and how you can support the implementation of recommendations for #MS, #NMOSD, #MOGAD and related disorders. MS Brain Health Oxford Health Policy Forum #MSBH #BrainHealthTM #NMOSDTimeMatters #MOGADTimeMatters

The work on digital biomarkers never sits still, and every conference is expanding on experiences from case studies, methodologies, etc. Great summary from Aude Clement on the key takeaways from this event.

U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation announced five Phase 2 winners in the LymeX Diagnostics Prize, a competition to accelerate the development of Lyme disease diagnostics. From January to September 2023, 10 teams participated in a virtual accelerator designed to help them refine their concepts for detecting active Lyme disease infections in people. The goal of this multiphase LymeX Innovation Accelerator (LymeX) competition is to nurture the development of diagnostics toward Food and Drug Administration review. The Phase 2 virtual accelerator offered access to virtual learning, mentorship, biorepository subject matter expertise, and networking opportunities designed to help the cohort progress toward FDA review. Phase 2 awarded $2 million in prizes based on the teams’ interim and final submissions. Discover the Phase 2 winners and read the entire release here: https://bit.ly/486R69R #CohenGive #lymedisease

We would like to extend our sincere thanks to the sponsors who were instrumental in making the 2nd Congress on Rare Diseases for Latin America and the Caribbean possible. Your support enabled key discussions, including the need for clear public policies, the importance of international collaboration, and innovative models like Casa dos Raros in Brazil. Panels explored the role of regulatory agencies, health technology assessments, and innovative financing strategies for rare diseases. Advocacy leaders and patient testimonials reinforced the importance of continued stakeholder engagement and a unified approach to improving care for those living with rare diseases. With over 1,500 participants, the congress focused on advancing critical discussions around rare diseases and identifying practical solutions to improve diagnostics, access to treatment, and patient care in the region. A special thanks to our Platinum sponsors, Amgen and AstraZeneca, for their ongoing commitment to rare disease care. We also thank our Gold sponsors, Chiesi Group, Takeda, Johnson & Johnson, Valentech Pharma, and MSD, for their valuable contributions to advancing rare disease research. In addition, we appreciate the support of our Silver sponsors, Boehringer Ingelheim, Sanofi, ARCHIMEDlife Medical Laboratories, Illumina, JCR Pharmaceuticals, and Multicare Pharma, and our Allies, Optimal Therapies, Farmacon Global, and RARASCRO. We look forward to continuing our collaboration to drive progress in rare disease care across Latin America and the Caribbean. Learn more about AHF and our work: https://lnkd.in/drNVhhwU #RareDiseases #Collaboration #Innovation #PublicPolicy #Healthcare #AccessToCare #Congress #ThankYou #LatinAmerica

How can we strengthen the ROI of incorporating digital biomarkers in drug development trials and accelerate its adoption… looking forward to hearing the sessions today and sharing the insights! #DigitalBiomarkersSummit #medidata #clinicalinnovation

Are you in the Life Sciences Eco-system and in the GTA? Here is an event to look into!

🌟 Inceptua at Clinical Trial Supply East Coast 2024! 🌟   The US election is almost upon us – your vote matters and your opinions matter. We want to hear your opinions about clinical trial supply … so what are the 2-3 hot topics you’d like to talk with us about if you had the chance? Over the 5th and 6th November we are delighted to announce that Inceptua will be exhibiting at the 22nd Annual Clinical Trial Supply East Coast 2024. Let us know your thoughts in the comments below – or even better, come and ask us in person!   We’ll be represented at the event by Michelle Novak, Jessica Derr, Jorge Franceschi (乔治), and Timothy Campbell - we’ll be easy to find at our event booth, so don’t be shy.   🔹 Event Details: 🗓️ Date: November 5-6, 2024 📍 Location: Sheraton Valley Forge, King of Prussia, PA, USA   This event is a great opportunity to engage in insightful discussions, discover new strategies, and network with peers from across the clinical trial supply chain. We look forward to sharing our expertise and learning from the best in the industry.   Feel free to connect with our team on LinkedIn and reach out directly to set up a meeting! Let’s discuss how Inceptua can support your clinical trial supply needs and help you achieve your goals.   #Inceptua #ClinicalTrialSupply #CTSEastCoast2024 #ClinicalTrials #Pharma #Biotech #Pharma #Networking